These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 3000164)
1. Immunocytochemical demonstration of growth hormone-releasing factor in gastrointestinal and pancreatic endocrine tumors. Dayal Y; Lin HD; Tallberg K; Reichlin S; DeLellis RA; Wolfe HJ Am J Clin Pathol; 1986 Jan; 85(1):13-20. PubMed ID: 3000164 [TBL] [Abstract][Full Text] [Related]
2. Growth-hormone-releasing factor immunoreactivity in human endocrine tumors. Bostwick DG; Quan R; Hoffman AR; Webber RJ; Chang JK; Bensch KG Am J Pathol; 1984 Nov; 117(2):167-70. PubMed ID: 6093542 [TBL] [Abstract][Full Text] [Related]
3. Multihormonal carcinoid tumor of the pancreas. Secreting growth hormone-releasing factor as a cause of acromegaly. Berger G; Trouillas J; Bloch B; Sassolas G; Berger F; Partensky C; Chayvialle JA; Brazeau P; Claustrat B; Lesbros F Cancer; 1984 Nov; 54(10):2097-108. PubMed ID: 6435852 [TBL] [Abstract][Full Text] [Related]
4. Acromegaly and Zollinger-Ellison syndrome secondary to an islet cell tumor: characterization and quantification of plasma and tumor human growth hormone-releasing factor. Wilson DM; Ceda GP; Bostwick DG; Webber RJ; Minkoff JR; Pont A; Hintz RL; Bensch KG; Kraemer FB; Rosenfeld RG J Clin Endocrinol Metab; 1984 Nov; 59(5):1002-5. PubMed ID: 6090497 [TBL] [Abstract][Full Text] [Related]
5. [Acromegaly, clinical expression of the production of growth hormone releasing factor in pancreatic tumors]. Sassolas G; Chayvialle JA; Partensky C; Berger G; Trouillas J; Berger F; Claustrat B; Cohen R; Girod C; Guillemin R Ann Endocrinol (Paris); 1983; 44(6):347-54. PubMed ID: 6430207 [TBL] [Abstract][Full Text] [Related]
6. Human hypothalamic growth hormone releasing factor (GRF): evidence for two forms identical to tumor derived GRF-44-NH2 and GRF-40. Böhlen P; Brazeau P; Bloch B; Ling N; Gaillard R; Guillemin R Biochem Biophys Res Commun; 1983 Aug; 114(3):930-6. PubMed ID: 6412708 [TBL] [Abstract][Full Text] [Related]
7. Reversible sellar enlargement due to growth hormone-releasing hormone production by pancreatic endocrine tumors in a acromegalic patient with multiple endocrine neoplasia type I syndrome. Ramsay JA; Kovacs K; Asa SL; Pike MJ; Thorner MO Cancer; 1988 Jul; 62(2):445-50. PubMed ID: 2898285 [TBL] [Abstract][Full Text] [Related]
8. Immunohistological localization of growth hormone-releasing hormone in human tumors. Asa SL; Kovacs K; Thorner MO; Leong DA; Rivier J; Vale W J Clin Endocrinol Metab; 1985 Mar; 60(3):423-7. PubMed ID: 3919041 [TBL] [Abstract][Full Text] [Related]
9. Primary endocrine-secreting pancreatic tumors. Macaron C Am Fam Physician; 1980 Apr; 21(4):94-8. PubMed ID: 6103668 [TBL] [Abstract][Full Text] [Related]
10. Reduction of pituitary size by the somatostatin analogue SMS 201-995 in a patient with an islet cell tumour secreting growth hormone releasing factor. Wilson DM; Hoffman AR Acta Endocrinol (Copenh); 1986 Sep; 113(1):23-8. PubMed ID: 2876570 [TBL] [Abstract][Full Text] [Related]
11. [Immunohistochemical detection of growth hormone-releasing factor (GRF) in neuroendocrine tumors]. Gottschalk J; Rohde W Acta Histochem Suppl; 1988; 35():207-12. PubMed ID: 2843943 [TBL] [Abstract][Full Text] [Related]
12. [Hormone immunocytochemical studies of 46 endocrine tumors of the pancreas in 24 patients]. Le Bodic MF; Cloarec D; Lehur PA; Visset J; Le Bodic L Gastroenterol Clin Biol; 1986 Apr; 10(4):334-40. PubMed ID: 3013709 [TBL] [Abstract][Full Text] [Related]
13. Current status of the apudomas. Welbourn RB Ann Surg; 1977 Jan; 185(1):1-12. PubMed ID: 12724 [No Abstract] [Full Text] [Related]
14. Production and secretion of immunoreactive growth hormone-releasing factor by pheochromocytomas. Sano T; Saito H; Yamasaki R; Hosoi E; Kameyama K; Saito S; Hirose T; Hizawa K Cancer; 1986 May; 57(9):1788-93. PubMed ID: 2869833 [TBL] [Abstract][Full Text] [Related]
15. A rare cause of acromegaly: ectopic production of growth hormone-releasing factor by a bronchial carcinoid tumor. Garcia-Luna PP; Leal-Cerro A; Montero C; Scheithauer BW; Campanario A; Dieguez C; Astorga R; Kovacs K Surg Neurol; 1987 Jun; 27(6):563-8. PubMed ID: 3107152 [TBL] [Abstract][Full Text] [Related]
16. Pancreatic lesions and hormonal profile of pancreatic tumors in multiple endocrine neoplasia type I. An immunocytochemical study of nine patients. Klöppel G; Willemer S; Stamm B; Häcki WH; Heitz PU Cancer; 1986 May; 57(9):1824-32. PubMed ID: 2420439 [TBL] [Abstract][Full Text] [Related]
17. The analysis of immunophenotype of gastrin-producing tumors of the pancreas and gastrointestinal tract. Gurevich L; Kazantseva I; Isakov VA; Korsakova N; Egorov A; Kubishkin V; Bulgakov G Cancer; 2003 Nov; 98(9):1967-76. PubMed ID: 14584081 [TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide 1 immunoreactivity in gastroentero-pancreatic endocrine tumors: a light- and electron-microscopic study. Eissele R; Göke R; Weichardt U; Fehmann HC; Arnold R; Göke B Cell Tissue Res; 1994 Jun; 276(3):571-9. PubMed ID: 8062345 [TBL] [Abstract][Full Text] [Related]
19. Growth hormone-releasing hormone (GHRH)-secreting pancreatic tumor in a patient with multiple endocrine neoplasia type I. Sano T; Yamasaki R; Saito H; Hirose T; Kudo E; Kameyama K; Hiraishi K; Saito S; Hizawa K Am J Surg Pathol; 1987 Oct; 11(10):810-9. PubMed ID: 2889383 [TBL] [Abstract][Full Text] [Related]
20. Retrospective study of 77 pancreatic endocrine tumors using the immunoperoxidase method. Mukai K; Grotting JC; Greider MH; Rosai J Am J Surg Pathol; 1982 Jul; 6(5):387-99. PubMed ID: 6127037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]